loss p16ink4a confers susceptibility metastatic melanoma mice
cdkn2a ink4a/arf frequently disrupted various types human cancer germline mutations locus can confer susceptibility melanoma tumours however cdkn2a encodes two distinct cell cycle inhibitory proteins p16ink4a p14arf p19arf mice mechanism tumour suppression cdkn2a remained controversial genetic disruption cdkn2ap19arf hereafter arf alone predisposes mice tumorigenesis demonstrating arf tumour-suppressor gene mice mutated mice specifically cdkn2ap16ink4a hereafter ink4a demonstrate mice designated ink4a*/* show significant predisposition spontaneous tumour formation within months embryo fibroblasts derived proliferate normally mortal transformed oncogenic hras mild phenotype ink4a*/* mice implies strong phenotypes original ink4a/arfdelta2 mice primarily solely due loss arf however ink4a*/ delta mice deficient ink4a heterozygous arf spontaneously develop wide spectrum tumours including melanoma treatment mice carcinogen -dimethylbenzanthracene dmba results increased incidence melanoma frequent metastases results show mouse ink4a tumour-suppressor gene lost can recapitulate tumour predisposition seen humans
